IQVIA Holdings | درآمد حاصل از بهره



Interest Income تغییر دادن تاریخ
Accenture USD 76.03M 24.71M 2024-11
Agilent USD 15M 9M 2025-01
Bruker 2.4M 2.4M 2024-12
Celltrion KRW 8.96B 1.67B 2024-09
Charles River Laboratories USD 1.84M 307K 2024-12
Cognizant Technology Solutions USD 28M 3M 2024-12
Danaher USD 14M 10M 2024-12
Dentsply International 5M 0 2024-09
Dianthus Therapeutics USD 4.44M 263K 2024-09
Hologic USD 24.2M 4.2M 2024-12
IBM 3.11 3.47 2024-12
Illumina USD 10M 1000K 2024-12
Infosys INR 5.91B 0 2024-12
Kangmei Pharma 4.31M 8.34M 2024-09
Knight Therapeutics CAD 2.46M 498K 2024-09
Laboratorios Farma 97K 94K 2024-06
Pharma Mar 4.8M 6.4M 2024-12
Qiagen NV USD 15.09M 3.16M 2024-12
Quest Diagnostics USD 1.95 0.04 2024-12
Revvity USD 9.83M 12.94M 2024-12
Sartorius 11.6M 6M 2024-09
Thermo Fisher Scientific USD 227M 50M 2024-12
Tilray USD 12.83M 20.19M 2024-05
Waters USD 4.56M 301K 2024-12
Zhangzhou Pientzehuang Pharmaceutical 11.93M 13M 2024-09



IQVIA Holdings درآمد حاصل از بهره - ارزش های فعلی، داده های تاریخی، پیش بینی، آمار، نمودار و تقویم اقتصادی - Mar 2025.